14-day Premium Trial Subscription Try For FreeTry Free
--Company to Host Conference Call on Tuesday, November 16, 2021, at 8:30AM ET-- --Company to Host Conference Call on Tuesday, November 16, 2021, at 8:30AM ET--
The FDA has declined the emergency use authorization (EUA) for NRx Pharmaceuticals' (NASDAQ: NRXP) Zyesami (aviptadil).  The Company is developing aviptadil in collaboration with Relief Therapeu

1 Small-Cap Stock With 10X Potential

07:45am, Wednesday, 27'th Oct 2021
This company's coronavirus efforts could pay off big time.
These two tiny drugmakers could make early shareholders wealthy.
The drugmaker is being sued by Relief Therapeutics.
GENEVA, SWITZERLAND / ACCESSWIRE / October 15, 2021 / RELIEF THERAPEUTICS Holding SA (SIX:RLF, OTCQB:RLFTF) (" Relief "), a biopharmaceutical company seeking to provide patients therapeutic relief fro
NRx Pharmaceuticals Inc (NASDAQ:NRXP) burst onto the scene today, tacking on 35.3% to trade at $12.77 at last check, following the publication of peer-reviewed results from a controlled trial of NRx's
New clinical trial results bode well for aviptadil in treating critically ill COVID-19 patients.

Why NRX Pharmaceuticals Stock Is Surging Today

10:27am, Thursday, 14'th Oct 2021
NRX Pharmaceuticals Inc (NASDAQ: NRXP) is trading significantly higher Thursday after the company announced the Journal of Infectious Diseases and Treatment published trial data of aviptadil in high
NRX Pharmaceuticals (NRXP) stock is surging higher on Thursday thanks to recent results from a clinical trial of its Covid-19 treatment. The post NRXP Stock: The Critical Covid-19 Trial Results That H
RADNOR, Pa., Oct. 14, 2021 /PRNewswire/ -- NRx Pharmaceuticals (Nasdaq: NRXP), today announced the publication of peer-reviewed results from a prospective, open-label, administratively controlled tri
Shares of NRX Pharmaceuticals Inc. (NASDAQ: NRXP) spiked in price by over 60% on Tuesday due to positive news from the FDA related to their product Zyesami. This could be the return of their shares af

NRXP Stock: Why It Substantially Increased

05:20am, Wednesday, 13'th Oct 2021
The stock price of NRx Pharmaceuticals Inc (NASDAQ: NRXP) increased by over 61% yesterday. This is why it happened.

Why NRX Pharmaceuticals Shares Are Rising

03:54pm, Tuesday, 12'th Oct 2021
NRX Pharmaceuticals Inc (NASDAQ: NRXP) shares are trading higher by 54.1% at $10.45 after the company announced progress on the worldwide commercial-scale development of ZYESAMI. The company announced
The company announced progress on two fronts for its experimental COVID-19 drug Zyesami.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE